| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immix Biopharma, Inc. (IMMX) has 9 insiders with recent SEC Form 4 filings, including 13 buys and 0 sells. IMMX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.14M | $11.90M | - | |
| CFO | 291.4K | $3.04M | - | |
| Dir | 39.6K | $413.3K | - | |
| 10% | 33.0K | $344.0K | - | |
| Dir | 33.0K | $344.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2025 | Rachman Ilya M64 | CEO And Chairman | Buy | 746 | $6.67 | $4,975.82 | - | +54.5% | - | |
| Dec 10, 2025 | Morris Gabriel S65 | CFO | Buy | 770 | $6.58 | $5,066.60 | +0.3% | +54.5% | - | |
| Sep 17, 2025 | Rachman Ilya M64 | CEO And Chairman | Buy | 2,500 | $2.02 | $5,050.00 | +0.2% | +203.1% | - | |
| Sep 16, 2025 | Morris Gabriel S65 | CFO | Buy | 2,600 | $1.97 | $5,122.00 | +0.9% | +210.3% | - | |
| Jun 18, 2025 | Rachman Ilya M64 | CEO And Chairman | Buy | 2,178 | $2.30 | $4,998.51 | +0.2% | -16.3% | - | |
| Jun 18, 2025 | Morris Gabriel S65 | CFO | Buy | 2,225 | $2.28 | $5,070.78 | +0.8% | -16.3% | - | |
| Dec 23, 2024 | Hsu Jason50 | Director | Buy | 47,700 | $2.19 | $104,358.20 | +2.8% | -16.5% | +160.1% | |
| Aug 22, 2024 | Hsu Jason50 | Director | Buy | 23,100 | $2.23 | $51,623.10 | +1.4% | -17.6% | -0.9% | |
| Aug 16, 2024 | Ng Carey | Director | Buy | 10,000 | $1.86 | $18,600.00 | +100.0% | -14.7% | +19.5% | |
| Jul 24, 2024 | Hsu Jason50 | Director | Buy | 9,200 | $2.12 | $19,516.56 | +0.6% | -19.9% | +35.4% |